Literature DB >> 12216576

Erectile-dysfunction therapies.

Ronald C Renaud, Hayley Xuereb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12216576     DOI： 10.1038/nrd898

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

Review 2.  Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs).

Authors:  Win Min Oo; David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-20       Impact factor: 3.625

3.  A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.

Authors:  Hsiao-Rong Chen; David H Sherr; Zhenjun Hu; Charles DeLisi
Journal:  BMC Med Genomics       Date:  2016-07-30       Impact factor: 3.063

4.  Transcriptional data: a new gateway to drug repositioning?

Authors:  Francesco Iorio; Timothy Rittman; Hong Ge; Michael Menden; Julio Saez-Rodriguez
Journal:  Drug Discov Today       Date:  2012-08-07       Impact factor: 7.851

5.  Drug repurposing in the era of COVID-19: a call for leadership and government investment.

Authors:  Jennifer H Martin; Nikola A Bowden
Journal:  Med J Aust       Date:  2020-05-06       Impact factor: 7.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.